-
JAMA Psychiatry
Original Investigation
February 7, 2024
Emily Lipner, MA; Naoise Mac Giollabhui, PhD; Elizabeth C. Breen, PhD; Barbara A. Cohn, MPH, MCP, PhD; Nickilou Y. Krigbaum, MPH; Piera M. Cirillo, MPH; Thomas M. Olino, PhD; Lauren B. Alloy, PhD; Lauren M. Ellman, PhD
online first
JAMA Psychiatry. 2024; 10.1001/jamapsychiatry.2023.5458
This cohort study evaluates associations between maternal inflammatory biomarkers in pregnancy and depressive symptoms in their offspring.
-
JAMA Psychiatry
Original Investigation
September 20, 2023
Melanie H. Jacobson, PhD, MPH; Ghassan B. Hamra, PhD; Catherine Monk, PhD; Rosa M. Crum, MD, MHS; Sudhindra Upadhyaya, MS; Lyndsay A. Avalos, PhD, MPH; Theresa M. Bastain, PhD, MPH; Emily S. Barrett, PhD; Nicole R. Bush, PhD; Anne L. Dunlop, MD, MPH; Assiamira Ferrara, MD, PhD; Morgan R. Firestein, PhD; Alison E. Hipwell, PhD, ClinPsyD; Kurunthachalam Kannan, PhD; Johnnye Lewis, PhD; John D. Meeker, ScD, CIH; Douglas M. Ruden, PhD; Anne P. Starling, PhD; Deborah J. Watkins, PhD; Qi Zhao, MD, PhD; Leonardo Trasande, MD, MPP; Environmental Influences on Child Health Outcomes Consortium
JAMA Psychiatry. 2023; 81(1):67-76. 10.1001/jamapsychiatry.2023.3542
This cohort study investigates the association between prenatal exposure to nonpersistent environmental chemicals and postpartum depression symptoms.
-
JAMA Psychiatry
Viewpoint
August 2, 2023
Gregory K. Farber, PhD; Suzanne Gage, PhD; Danielle Kemmer, PhD
JAMA Psychiatry. 2023; 80(10):981-982. 10.1001/jamapsychiatry.2023.2282
This Viewpoint provides a summary of a new project launched by a coalition of research funders and journals to improve the measures used in mental health research.
-
JAMA Psychiatry
Original Investigation
July 12, 2023
Graham Blackman, MBChB; Giulia Neri, MSc; Omar Al-Doori, MSc; Maria Teixeira-Dias, MSc; Asif Mazumder, MBBS; Thomas A. Pollak, PhD; Emily J. Hird, PhD; Nikolaos Koutsouleris, PhD; Vaughan Bell, PhD; Matthew J. Kempton, PhD; Philip McGuire, MBChB, MD, PhD
open access
JAMA Psychiatry. 2023; 80(10):1047-1054. 10.1001/jamapsychiatry.2023.2225
This systematic review and meta-analysis examines data from studies of patients with first-episode psychosis to estimate the prevalence of clinically relevant neuroradiological abnormalities detected using magnetic resonance imaging.
-
JAMA Psychiatry
Original Investigation
May 24, 2023
Emma McLachlan, PhD; Dilek Ocal, MSc; Neil Burgess, PhD; Suzanne Reeves, PhD; Robert Howard, MD; Alzheimer’s Disease Neuroimaging Initiative
JAMA Psychiatry. 2023; 80(7):700-709. 10.1001/jamapsychiatry.2023.1012
This cross-sectional study uses behavioral testing and volumetric neuroimaging data to examine the association between false memories and delusions among individuals in the Alzheimer Disease Neuroimaging Initiative cohort.
-
JAMA Psychiatry
Special Communication
December 7, 2022
Joshua S. Siegel, MD, PhD; James E. Daily, JD; Demetrius A. Perry, MA; Ginger E. Nicol, MD
is active quiz
JAMA Psychiatry. 2022; 80(1):77-83. 10.1001/jamapsychiatry.2022.4101
This Special Communication assesses trends in psychedelics legislative reform and legalization in the US.
-
JAMA Psychiatry
Comment & Response
November 23, 2022
Zindel V. Segal, PhD, CPsych
JAMA Psychiatry. 2022; 80(1):95-96. 10.1001/jamapsychiatry.2022.3742
-
JAMA Psychiatry
Original Investigation
August 31, 2022
Phil H. Lee, PhD; Alysa E. Doyle, PhD; Micah Silberstein, BS; Jae-Yoon Jung, PhD; Richard T. Liu, PhD; Roy H. Perlis, MD; Joshua Roffman, MD; Jordan W. Smoller, MD, ScD; Maurizio Fava, MD; Ronald C. Kessler, PhD
open access
JAMA Psychiatry. 2022; 79(10):971-980. 10.1001/jamapsychiatry.2022.2379
This case-control study examines whether genetic susceptibility to suicide attempts is associated with suicidal thoughts and behaviors in children.
-
JAMA Psychiatry
Original Investigation
April 27, 2022
Matthew Miller, MD, MPH, ScD; Yifan Zhang, PhD; Lea Prince, PhD; Sonja A. Swanson, ScD; Garen J. Wintemute, MD, MPH; Erin E. Holsinger, MD; David M. Studdert, LLB, ScD
free access
JAMA Psychiatry. 2022; 79(6):582-588. 10.1001/jamapsychiatry.2022.0793
This cohort study evaluates suicide rates among women who do not own guns with and without cohabitants who own guns.
-
JAMA Psychiatry
Original Investigation
April 27, 2022
Yunyu Xiao, PhD; Paul Siu-Fai Yip, PhD; Jyotishman Pathak, PhD; J. John Mann, MD
open access
is active quiz
JAMA Psychiatry. 2022; 79(6):610-621. 10.1001/jamapsychiatry.2022.0818
This cohort study investigates the association of individual and structural social determinants of health and vaccinations with child mental health during the COVID-19 pandemic in the US.
-
JAMA Psychiatry
Original Investigation
February 9, 2022
Sarah W. Yip, PhD; Ayana Jordan, MD, PhD; Robert J. Kohler, PhD; Avram Holmes, PhD; Danilo Bzdok, MD, PhD
free access
is active quiz
JAMA Psychiatry. 2022; 79(4):350-358. 10.1001/jamapsychiatry.2021.4331
This cohort study identifies baseline predictors of COVID-19 pandemic experiences, as defined by both child and parent report, using data from the Adolescent Brain and Cognitive Development cohort.
-
JAMA Psychiatry
Special Communication
September 22, 2021
Ronald C. Kessler, PhD; Alex Luedtke, PhD
JAMA Psychiatry. 2021; 78(12):1384-1390. 10.1001/jamapsychiatry.2021.2500
This Special Communication describes pragmatic precision psychiatry, which is the branch of precision psychiatry focused on matching patients to best currently available interventions.
-
JAMA Psychiatry
Viewpoint
June 23, 2021
David Mataix-Cols, PhD; Erik Andersson, PhD
JAMA Psychiatry. 2021; 78(9):943-944. 10.1001/jamapsychiatry.2021.1419
This Viewpoint presents suggestions for improving the integrity of and reporting on blinding in trials testing psychotherapeutic methods.
-
JAMA Psychiatry
Editorial
June 16, 2021
Joseph T. Coyle, MD; Dost Öngür, MD, PhD
JAMA Psychiatry. 2021; 78(8):823-823. 10.1001/jamapsychiatry.2021.1318
-
JAMA Psychiatry
Original Investigation
March 31, 2021
Michael Fairley, PhD; Keith Humphreys, PhD; Vilija R. Joyce, MS; Mark Bounthavong, PharmD, PhD; Jodie Trafton, PhD; Ann Combs, MHA; Elizabeth M. Oliva, PhD; Jeremy D. Goldhaber-Fiebert, PhD; Steven M. Asch, MD, MPH; Margaret L. Brandeau, PhD; Douglas K. Owens, MS, MD
free access
has multimedia
JAMA Psychiatry. 2021; 78(7):767-777. 10.1001/jamapsychiatry.2021.0247
This study evaluates the cost-effectiveness of medication-assisted treatment and treatment add-ons (eg, contingency management) for opioid use disorder.
-
-
JAMA Psychiatry
Editorial
September 19, 2019
Dost Öngür, MD, PhD
free access
JAMA Psychiatry. 2019; 76(11):1115-1116. 10.1001/jamapsychiatry.2019.3127
-
JAMA Psychiatry
Special Communication
May 13, 2020
Myrna M. Weissman, PhD
JAMA Psychiatry. 2020; 77(9):967-973. 10.1001/jamapsychiatry.2020.0954
This Special Communication describes population surveys, cohort studies, administrative claims, large genetic data sets, and electronic health records published in JAMA Psychiatry between 1979 and 2019.
-
JAMA Psychiatry
Editorial
March 25, 2020
Dost Öngür, MD, PhD
free access
JAMA Psychiatry. 2020; 77(5):451-452. 10.1001/jamapsychiatry.2020.0102
-
JAMA Psychiatry
Original Investigation
October 30, 2019
Yuelong Ji, PhD; Romuladus E. Azuine, DrPH, MPH, RN; Yan Zhang, PhD; Wenpin Hou, PhD; Xiumei Hong, MD, PhD; Guoying Wang, MD, PhD; Anne Riley, PhD; Colleen Pearson, BA; Barry Zuckerman, MD; Xiaobin Wang, MD, MPH, ScD
free access
JAMA Psychiatry. 2019; 77(2):180-189. 10.1001/jamapsychiatry.2019.3259
This cohort study of mother-infant dyads examines the associations between cord plasma acetaminophen metabolites and physician-diagnosed attention-deficit/hyperactivity disorder, autism spectrum disorder, and other developmental disabilities.